Rocuronium Bromide Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Rocuronium Bromide Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on 02/15/2023.
Shortage Details
- Status
- Current
- Company
- Fresenius Kabi USA, LLC
- Package NDC
- 63323-426-05
- Dosage Form
- Injection
- Presentation
- Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-05)
- Initial Posting
- 02/15/2023
- Revised Date